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biopsy of right adrenal mass. Clinically, the 
patient suffered from continuous pain in 
the right lumbar region, a significant weight 
loss in the past two months (about 15 kg), 
and severe asthenia. Before hospitalization, 
IntroduCtIon
Angiosarcomas are malignant tumors 
arising from the endothelial lining of blood 
vessels and accounting for less than 1% of 
all soft tissue sarcomas, which represent 1% 
of all solid tumors in adults. That means 
that the incidence of angiosarcoma is 0.1-
0.2/100,000 per year. Adrenal gland is an 
uncommon site for angiosarcoma. Usually, it 
occurs in skin, soft tissue, breast, bone, liver, 
and spleen and has poor long-term prognosis 
[1]. No predisposing factors for primary ad-
renal angiosarcoma have been identified yet.
Case report
A 55-year-old woman was admitted to our 
Urology Unit on January 2014 to undergo a 
Why we describe this case
Epithelioid angiosarcoma of the adrenal 
gland is a very rare and aggressive tumor, 
with no specific clinical or radiological 
patterns. Diagnosis requires detailed 
pathologic examination accompanied 
by immunohistochemical studies using 
endothelial markers. When FNA is used 
for diagnosis, this process becomes much 
challenging due to the minimal amount 
of tissue available for examination
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Case report
abstract
Primary epithelioid angiosarcoma of the adrenal gland is extremely rare. Only 37 cases have 
been reported in the scientific literature.
Here we describe the case of a 55-year-old woman affected by metastatic angiosarcoma in the 
right adrenal gland, who died few days after the histological diagnosis made by fine-needle 
aspiration (FNA). This is the second case of primary epithelioid angiosarcoma diagnosed by FNA 
among scientific articles published in English in PubMed. Microscopically, the tumor showed a 
predominant epithelioid differentiation, thus making the diagnostic process more difficult than 
usual. Immunohistochemical examination revealed positive reactivity for cytokeratin, CD31, 
and CD34. The literature shows that epithelioid adrenal angiosarcoma has poor clinical outcome, 
especially when metastatic at presentation. 
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ultrasonography showed a nonspecific mass 
located around the upper pole of the right 
kidney and abdominal computed tomogra-
phy revealed a right adrenal neoplasm mea-
suring 45 × 29 mm in diameter and bulging 
out toward the liver (Figures 1 and 2).
Physical examination revealed a tender 
palpable right upper quadrant mass. Labo-
ratory studies were significant for anemia 
(6.2 g/dl) and leukocytosis (1.19 × 103/µl). 
Hormone panel including serum and uri-
nary metanephrines, serum and urinary 
cortisol, plasma aldosterone, and serum 
adrenocorticotropic hormone was normal. 
Ten days after hospitalization, follow up 
chest-abdomen and pelvis CT scan re-
Figure 1. 
Ultrasonography 
showing right adrenal 
mass (red arrow) 
infiltrating the upper 
pole of kidney and 
liver (one month before 
hospital admission)
Figure 2. Abdominal 
computed tomography 
revealing the same 
adrenal mass (red 
arrow) in trasversal 
plan (one month before 
hospital admission)
vealed enlargement of the adrenal mass 
from 45 × 29 mm to 65 × 45 mm. New 
bilateral lung nodules were also noted (Fig-
ures 3 and 4).
Therefore, fine-needle aspiration (FNA) 
was performed. Histological sections 
showed sheets of epithelioid cells in a fi-
brotic stroma and focal necrosis. Cells have 
eosinophilic cytoplasm, prominent nucleoli 
and frequent mitotic figures. These histo-
logic features were consistent with malig-
nant neoplasm. Further studies with pax8, 
cytokeratin 19, claudin, calretinin, synapto-
physin, chromogranin A, glypican-3, human 
melanoma black 45 and MART-1, and cy-
tokeratin (AE1/AE3) were performed. The 
Figure 3. CT scan 
revealing growing 
adrenal mass (red 
arrow) with extensive 
infiltration of liver and 
upper pole of kidney 
(longitudinal plan, 
ten days after hospital 
admission)
Figure 4. CT scan 
showing evidence 
of lung metastasis 
(red arrow) in right 
pulmonary lobe (ten 
days after hospital 
admission)
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vealed enlargement of the adrenal mass 
from 45 × 29 mm to 65 × 45 mm. New 
bilateral lung nodules were also noted (Fig-
ures 3 and 4).
Therefore, fine-needle aspiration (FNA) 
was performed. Histological sections 
showed sheets of epithelioid cells in a fi-
brotic stroma and focal necrosis. Cells have 
eosinophilic cytoplasm, prominent nucleoli 
and frequent mitotic figures. These histo-
logic features were consistent with malig-
nant neoplasm. Further studies with pax8, 
cytokeratin 19, claudin, calretinin, synapto-
physin, chromogranin A, glypican-3, human 
melanoma black 45 and MART-1, and cy-
tokeratin (AE1/AE3) were performed. The 
Figure 3. CT scan 
revealing growing 
adrenal mass (red 
arrow) with extensive 
infiltration of liver and 
upper pole of kidney 
(longitudinal plan, 
ten days after hospital 
admission)
Figure 4. CT scan 
showing evidence 
of lung metastasis 
(red arrow) in right 
pulmonary lobe (ten 
days after hospital 
admission)
tumor cells were positive for cytokeratin 
and negative for all the remaining markers. 
A second panel of immunostains including 
CD31, cytokeratin, and ERG-1 was per-
formed. Tumor cells were strongly positive 
for all (Figure 5). Hence, the diagnosis of 
epithelioid angiosarcoma was made. Unfor-
tunately, the patient died few days after the 
histological diagnosis.
dIsCussIon
Angiosarcomas are very rare malignant 
tumors, which derive from the vascular en-
dothelium and can occur at any site in the 
body [2]. Epithelioid angiosarcoma (EA) 
of the adrenal gland has poor prognosis: 
5-year overall survival ranges between 25% 
and 45% in primary tumors, while is shorter 
than 12 months in metastatic patients [3]. 
To our knowledge, just 37 case reports have 
What should the clinician ask 
him/ herself or the patient
 y Adrenal mass is rapidly growing?
 y Are there general symptoms as asthenia, 
malaise, and mild fever?
 y Hormonal activity is normal?
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been reported in literature. Nevertheless, 
among them, only 29 are available for full 
review in English, according to PubMed 
systemic research through MeSH terms 
(Table I) [4-33].
The etiology of EA remains unknown: 
apart from a case of exposure to arsenic [6] 
and a case of exposure to vynil chloride [29], 
the published case reports didn’t succeed in 
identifying a clear correlation with the pa-
tients’ exposure to carcinogens or with a 
significant incidence of other diseases, even 
though three patients had concomitant ad-
renal cortical adenoma [26,31,32] (Table I).
Figure 5. 
Hematoxylin-eosin 
(H.E.) staining and 
immunohistochemical 
studies
Ck = cytokeratin
Case
Gender 
(age)
Clinical  
findings
Ct scan 
findings
side
other 
disease
therapy Follow up ref.
1 M (54) Abdominal pain 6 cm solid mass L None Adrenalectomy 
+ chemotherapy
Relapse after 7 
months
4
2 F (54) Fatigue, weight 
loss, paraneoplastic 
syndrome
6 cm soft tissue 
upper pole right 
kidney
R None Adrenalectomy NED 6 months 5
3 M (58) Abdominal pain 8 cm solid mass R Chronic 
arsenical 
intoxication
Adrenalectomy Died after surgery 6
4 M (41) Epigastric pain 10 cm rounded 
mass
R Mesenteric 
fibromatosis
Adrenalectomy 
+ radiotherapy
NA 7
5 M (67) Abdominal pain Inhomogeneous 
mass (13 cm)
L None Adrenalectomy Died 2 months for 
lung mts
8
6 M (85) Incidental findings 
(autopsy)
NA R None None None 9
7 F (60) Abdominal pain NA R None Adrenalectomy NED 13 years 9
Continues >
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Case
Gender 
(age)
Clinical  
findings
Ct scan 
findings
side
other 
disease
therapy Follow up ref.
8 F (64) Weight loss 10 cm suprarenal 
mass
L None Adrenalectomy Died 12 months 9
9 F (60) Left flank pain Adrenal mass L None Adrenalectomy Died 2 months 9
10 M (82) Incidental finding NA NA NA Adrenalectomy Died 24 months (lung 
mts)
9
11 F (45) Cushing’s syndrome Adrenal mass R None Adrenalectomy NED 11 years 9
12 M (56) Fever, weakness Adrenal mass R None Adrenalectomy Died 6 months (lung 
mts)
9
13 F (56) Flank pain Adrenal mass L None Adrenalectomy 
+ chemotherapy
NED 6 years 9
14 M (50) Nausea, diarrhoea 5.5 solid mass, 
peritoneal mts
R None Adrenalectomy Died 9 months (ileus) 10
15 M (50) Fever, lumbar pain 6 cm solid mass 
bone, liver mts
R None Adrenalectomy 
+ partial 
hepatectomy
Died after surgery 11
16 M (62) Anorexia Adrenal mass (10 
cm)
L None Adrenalectomy Died 7 weeks 12
17 M (63) Incidental finding 3 cm solid mass L None Laparoscopic 
adrenalectomy
NA 13
18 M (70) Abdominal pain 8 cm solid mass R None Adrenalectomy Died 3 weeks 14
19 M (34) Cushing’s syndrome 4 cm irregular 
mass
L Pituitary 
adenoma
Adrenalectomy NED 2 years 15
20 F (70) Abdominal pain 5 cm solid mass R Cistobiliary 
adenoma
Adrenalectomy NED 18 months 16
21 M (61) Abdominal pain 12 cm irregular 
mass
R None Adrenalectomy 
+ nephrectomy
NED 3 years 17
22 M (71) NA NA NA NA Adrenalectomy NA 18
23 M (60) Abdominal pain 11 cm solid and 
cystic mass
L Colon 
polyposis
Adrenalectomy 
+ radiotherapy 
+ chemotherapy
Died 6 months (lung 
mts)
19
24 M (60) NA NA NA NA Adrenalectomy 
+ chemotherapy
NED 3 years 20
25 M (50) Renal colic 7 cm mass at the 
upper pole kidney
L None Adrenalectomy 
+ nephrectomy
NED 12 years 21
26 M (69) Incidental NA NA Prostate 
carcinoma
NA NA 22
27 M (49) Incidental Large and cystic 
mass
R Blunt 
abdominal 
trauma
Adrenalectomy NED 1 year 23
28 M (55) Abdominal mass, 
weight loss
10 cm solid mass R None Adrenalectomy Died 12 months (lung 
mts)
24
29 F (69) Legs swellings 12.5 cm 
inhomogeneous 
mass
R Chronic renal 
failure
Adrenalectomy 
+ nephrectomy
NA 25
30 M (35) Hypertension 6 cm 
inhomogeneous 
mass
R Adrenocortical 
adenoma
Laparoscopic 
adrenalectomy
NED 2 years 26
31 M (61) Fatigue, weight loss Hypo-dense 
space-occupying 
lesion (PET)
R Epicardial mts Adrenalectomy NA 27
Continues >
> Continued
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Case
Gender 
(age)
Clinical  
findings
Ct scan 
findings
side
other 
disease
therapy Follow up ref.
32 M (42) Flank pain Hypervascular 
solid mass 
(14 cm)
R Cystic lesion 
of the adrenal 
gland
Adrenalectomy 
and nephrectomy
Died 3 months (liver 
mts)
28
33 M (68) Left sided chest pain Heterogeneous 
mass (7 cm)
L Vynil chloride 
exposition
Laparoscopic 
adrenalectomy
Died 7 months (bone 
mts)
29
34 M (55) Abdominal mass, 
weight loss
14 cm solid mass L None Adrenalectomy NA 30
35 F (60) Hypertension 5 cm solid mass L Adrenal 
cortical 
adenoma
Laparoscopic 
adrenalectomy
NED 9 months 31
36 M (63) Weight loss 8 cm solid mass R Adrenal 
cortical 
adenoma
Adrenalectomy NA 32
37 M (67) Hypertension 16 cm 
heterogeneous 
mass
R Left renal cell 
carcinoma
Adrenalectomy NED 12 months 33
table I. Case reports 
on epithelioid 
angiosarcomas retrieved 
in PubMed
L = left; mts = metastasis; 
NA = not available; 
NED = no evidence of 
disease; R = right
The disease occurs more frequently in 
males (M/F= 28/9), ranges from 34 to 85 
years of age, with a mean peak at 57 years.
Patients can either be asymptomatic or 
suffer from weight loss, slight fever, an-
orexia, fatigue, weakness, and chronic pain 
in the upper abdominal quadrants, as in 
our patient. No increase in adrenal gland 
hormones production is noted in most of 
the reported cases, even though two pa-
tients had Cushing’s syndrome [9,15] and 
in three patients the disease was discovered 
for the sudden onset of hypertension, de-
spite none of them had increased plasmatic 
aldosterone or metanephrines [26,31,33].
Actually, CT scan is the most used radio-
logical tool for diagnostic purpose, even if F18 
FDG PET/CT may be useful too [27]. Al-
though adrenal angiosarcoma does not have 
a distinct gross pattern, a review of the lit-
erature showed that it tends to have a round, 
solid, and heterogeneous aspect. Frequently, 
it is a cystic mass and can range in size from 
3 cm to 16 cm (Table I). Clinicians and pa-
thologists should include primary adrenal 
angiosarcoma in the differential diagnoses 
list for large adrenal gland mass [34].
One can speculate that the rich adrenal 
vasculature may create a favorable milieu 
for hemorrhagic and necrotic changes, while 
the high mitotic index may explain both the 
solid pattern and the huge volume of the 
tumor that is often found.
In this case, the differential diagnosis in-
cludes metastatic malignancy and other pri-
mary adrenal tumors. Epithelioid angiosarco-
mas can imitate carcinomas morphologically 
and immune-phenotypically. Metastatic or 
primary melanoma can also show both epi-
thelioid and spindled morphology. Among 
benign and malignant neoplasms that may 
simulate epithelioid angiosarcoma, there are 
adrenal adenoma undergoing massive hemor-
rhage and epithelioid hemangioendothelio-
ma. Moreover, the diagnosis of angiosarcoma 
can be a challenge due to pathohistologic 
features mimicking intravascular papillary 
endothelial hyperplasia (IPEH – Masson’s 
tumor). IPEH is a benign, reactive process 
that cannot be radiologically differentiated 
from other benign or malignant lesions [35].
Because of its rarity, in literature there is 
only one previous case of adrenal angiosar-
coma diagnosed by fine-needle aspiration 
(FNA) [25]. In fact, owing to its epithelioid 
morphology, this tumor may be mistaken for 
other neoplasms. Sometimes, the difficult 
diagnosis may cause an insufficient surgical 
approach. If the tumor is confined to the 
adrenal gland, it is suggested to remove it, 
and also take the periadrenal fat tissue and 
pericaval or periaortic tissue out in order to 
eradicate any site of potential local tumor 
microinfiltration. Involved organs, such 
as liver, spleen, pancreas, kidney, or bowel 
must be removed [16]. Too often, patients 
undergo surgery before a proper diagnosis 
is made and the high incidence of local re-
lapses may sometimes be explained by in-
adequate approaches. Laparoscopy may be 
used carefully in district surgeries: among 
the studied case reports, it was used in four 
patients with a follow up no longer than one 
year [13,26,29,31].
> Continued
13
©SEEd Tutti i diritti riservati
Clinical  Management  Issues   2017; 11(1)
T. Torelli, S. Radaelli, M. Colecchia, B. Paolini, M.A. Catanzaro, N. Nicolai, D. Biasoni, L. Piva, S. Stagni,  et al.
So far, diagnostic process is supported by 
histopathology and immunohistochemistry. 
Epithelioid angiosarcomas are morphologi-
cal variants of angiosarcomas, in which po-
lygonal endothelial cells with “epithelioid” 
appearance predominate and are often ar-
ranged in solid nests and sheets, mimicking 
carcinoma. Although irregular, anastomos-
ing vascular channels are commonly iden-
tified within the lesion, supporting the di-
agnosis. Malignant cells stain positively for 
endothelial markers CD31, factor VIII, and 
Fli-1. CD34 is reported to be less sensitive 
even though it is present in about 40% of 
cases (Table II).
Case Gross finding Ck Cd31 Cd34
Factor 
VIII
Ki-67 ref.
1 Solid and hemorrhagic mass NA NA NA NA NA 4
2 Solid mass with a central hemorrhagic mass Pos NA NA Pos NA 5
3 NA NA NA NA NA NA 6
4 Hemorrhagic cyst Pos NA NA Pos NA 7
5 Necrotic mass with nodules NA NA NA Pos NA 8
6-13 Solid cystic mass Pos NA Pos Pos NA 9
14 NA NA NA NA NA NA 10
15 Hemorrhagic cystic lesion Pos Pos Pos Pos NA 11
16 Hemorrhagic mass Pos Pos Pos Pos NA 12
17 Hemorrhagic mass Neg NA Pos Pos NA 13
18 Solid mass replacing the adrenal gland Pos Pos Pos Pos NA 14
19 Multiple soft reddish nodules Neg Pos Pos Pos 30% 15
20 Hemorrhagic lesion NA Pos NA NA NA 16
21 Hemorrhagic cystic mass Pos Pos Neg Neg NA 17
22 NA NA NA NA NA NA 18
23 Cystic mass with hemorrhagic areas Neg Pos Pos Pos NA 19
24 Hemorrhagic cyst Pos Pos Pos NA NA 20
25 Bilocular cyst containing thick material Neg Pos NA Pos NA 21
26 NA NA NA NA NA NA 22
27 Hemorrhagic mass NA NA NA NA NA 23
28 Solid mass with hemorrhagic foci Weak pos Pos Pos Pos NA 24
29 Biopsy: epithelioid cell Pos Pos Pos NA NA 25
30 Lobulated mass with hemorrhagic foci Pos Pos Pos Pos NA 26
31 NA NA NA NA NA NA 27
32 Cystic changes with old hemorrhage Pos Pos Neg Neg 60% 28
33 Infiltrating hemorrhagic noduli Focal pos Pos Neg Pos NA 29
34 NA NA NA NA NA NA 30
35 Solid mass with hemorrhagic areas Pos Pos Weak pos Weak pos NA 31
36 Areas of hemorrhage and necrosis Pos Pos Neg NA NA 32
37 Hematoma NA Pos Pos Pos NA 33
table II. 
Immunohistochemical 
and gross findings of 
reported cases
Ck = cytokeratin; 
NA = not available
Most epithelioid angiosarcomas co-ex-
press cytokeratin and diagnostic errors may 
be promoted by immunohistochemical re-
activity for this marker. In fact, cytokeratin 
reactivity may also occur in non-epithelial 
tumors like mesenchymal ones and the lit-
erature shows a lot of studies documenting 
the presence of cytokeratin in these tumors. 
Therefore, cytokeratin immunoreactivity 
may be considered as “aberrant expression” 
or “cross-reactivity” of this marker [36].
Surgery, combined with chemotherapy, 
represents the mainstay of treatment. Che-
motherapy is preferably used in neoadjuvant 
setting to shrink the tumor and eventually 
14
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ConClusIons
Epithelioid adrenal angiosarcoma is 
a very rare tumor and only 37 cases are 
reported in scientific literature. It is very 
aggressive and has poor long term prog-
nosis. Such data show that early diagnosis 
is mandatory. Nevertheless, early diagno-
sis is rarely made since the tumor may be 
asymptomatic or present with aspecific 
symptoms, like slight fever, anorexia, fa-
tigue or general pain or discomfort in the 
upper parts of the abdomen. Actually, en-
docrine tests are not indicative and the 
radiology workup may suggest just an in-
distinct malignancy. 
Even if histomorphological and immu-
nohistochemical studies are time-consum-
ing, they are an essential part of the defini-
tive diagnosis and FNA may be an helpful 
tool to obtain a preoperative and definitive 
diagnosis.
Unfortunately, sometimes diagnosis is 
made when disease is advanced, with no 
therapeutic options, as happened in this 
case.
Key points
 y Epithelioid adrenal angiosarcoma is a very rare and aggressive tumor
 y Even if early diagnosis is mandatory, endocrine tests are not indicative and radiology 
workup shows an indistinct malignancy
 y Histological diagnosis, supported by histopathology and immunohistochemistry, is essential 
for the best management performed by neoadjuvant chemotherapy and district surgery
 y It may be important for clinicians to obtain a preoperative diagnosis by FNA
prevent local or distant spread. In these cases, 
histological diagnosis is mandatory, before 
therapy and FNA may play an important 
role, because this tumor has not specific 
clinical or radiological patterns. Most ac-
tive agents are anthracycline, ifosfamide, 
gemcitabine, and taxanes.
In advanced or metastatic disease, cyto-
toxic chemotherapy based on the same ac-
tive drugs is the treatment of choice. Even 
if the response rate of angiosarcoma to these 
treatments is higher than other tumors, in 
most cases their dose-limiting toxic effects 
(mostly cardiac and neurological) do not 
allow to use these therapies longer than 6 
months [3]. Thus, new and non-toxic drugs 
are strongly needed. Among new anti-an-
giogenetic therapies, activity of sorafenib, 
sunitinib, bevacizumab, and thalidomide has 
been recently described, obtaining response 
rates up to 15% [37,38]. Especially in pal-
liative setting, where the goal is to increase 
survival and preserve the quality of life, the 
sequential use of taxanes and gemcitabine 
could be, probably in most cases, more ad-
visable than their combination [39].
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